Zobrazeno 1 - 10
of 66
pro vyhledávání: '"H, Schlechte"'
Autor:
S. Riethdorf, M. Barten, Christiane Ostwald, P. Gogacz, T. Löning, H. Schlechte, Reinhard E Friedrich, T. Bregenzer, L. Riethdorf, Karsten K.H. Gundlach, J. Becker, J. Sühwold
Publikováno v:
Mund-, Kiefer- und Gesichtschirurgie. 2:30-34
Es wurden Tumorgewebsproben von 110 Patienten mit Plattenepithelkarzinomen der Kopf-Hals-Region (KHPEK) untersucht. Mit Hilfe der Polymerasekettenreaktion (PCR) und anschliesender Temperaturgradientengelelektrophorese (TGGE) konnten in 48/110 Tumoren
Autor:
Thorsten H, Ecke, Horst H, Schlechte, Katrin, Schiemenz, Markus D, Sachs, Severin V, Lenk, Birgit D, Rudolph, Stefan A, Loening
Publikováno v:
Anticancer research. 30(5)
We assessed the predictive value of TP53 mutations and prostate-specific antigen (PSA) for tumor progression in prostate cancer (PCa) patients.Ninety tumor tissue samples of patients with PCa from radical prostatectomy were used. Tumor progression wa
Publikováno v:
International journal of molecular medicine. 21(5)
This study evaluates the influence of the TP53 genetic status on tumour recurrence and progression with a highly effective electrophoretic technique. DNA from tissue of 75 non-invasive urinary bladder cancers was PCR amplified in the TP53 exons 5-8 a
Autor:
Thorsten H, Ecke, Horst H, Schlechte, Anne, Hübsch, Severin V, Lenk, Katrin, Schiemenz, Birgit D, Rudolph, Kurt, Miller
Publikováno v:
Anticancer research. 27(6B)
The predictive value of TP53 mutations and prostate-specific antigen (PSA) was assessed in prostate needle biopsies of samples without signs of malignancy for later affliction by prostate cancer (PCa). Comparison of mutation frequency and PSA level i
Publikováno v:
Urologic oncology. 26(5)
Objective Obesity is estimated to account for up to 20% of all cancer deaths. Mutations of TP53 are frequently correlated with tumor development and progression. We evaluated the effect of body mass index (BMI) and mutation status of tumor suppressor
Publikováno v:
Anticancer research. 23(2A)
Tissue polypeptide antigen (TPA) is a circulating complex of polypeptide fragments from cytokeratins 8, 18 and 19. It is a tumour-related protein. TPA is an indicator of higher cell proliferation. One function of TP53 is the suppression of apoptosis.
Publikováno v:
Mund-, Kiefer- und Gesichtschirurgie : MKG. 6(6)
The aim of this study was to determine the prevalence of mutations of the tumour suppressor gene TP53 in oral leukoplakias.Brush biopsy specimens of 43 oral leukoplakias, 26 oral squamous cell carcinomas (OSCC) for reference, and the oral mucosa of 4
Publikováno v:
Cancer detection and prevention. 24(1)
The relationship between expression of p53 protein in bladder cancer and tumor progression is known. In this paper, we attempt to study this phenomenon by molecular-genetic techniques. One hundred thirty-seven bladder tumor tissues were obtained from
Autor:
S, Riethdorf, R E, Friedrich, J, Sühwold, C, Ostwald, M, Barten, P, Gogacz, K K, Gundlach, H, Schlechte, J, Becker, T, Bregenzer, L, Riethdorf, T, Löning
Publikováno v:
Mund-, Kiefer- und Gesichtschirurgie : MKG. 2(1)
Mutations of the p53 gene are the most commonly observed genetic alterations in malignant tumors and are often associated with a loss of the tumor suppressor function of the p53 protein. We have analyzed specimens of head and neck squamous cell carci
Autor:
M. Barten, T. Löning, Karsten K.H. Gundlach, L. Riethdorf, J. Becker, Reinhard E Friedrich, H. Schlechte, S. Riethdorf, T. Bregenzer, Christiane Ostwald, P. Gogacz
Publikováno v:
Journal of oral pathologymedicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 26(7)
We analyzed specimens of head and neck squamous cell carcinomas (HNSCC) from 110 patients for p53 gene mutations, and 92 of them for human papillomavirus (HPV) infection, in order to evaluate the prognostic significance of these factors by comparison